Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mitotherapeutix

Mitotherapeutix
2014 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$264K LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of pharmaceutical products designed to offer treatment of cancer and degenerative liver disorders. The company's pharmaceutical products used for the treatment of diseases that can be targeted by modifying or influencing metabolic pathways in the cell, as well as help to disrupt or correct the metabolic processes, enabling physicians to treat patients suffering from cancer and liver diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Cell & Genome Sciences Building
  • 400 Farmington Avenue, CB#123
  • Farmington, CT 06032
  • United States

+1 (203) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mitotherapeutix’s full profile, request a free trial.

Mitotherapeutix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Jan-2018 $264K 00.000 Completed Product Development
5. Early Stage VC 28-Dec-2017 00000 00.000 Completed Product Development
4. Accelerator/Incubator 18-Oct-2017 00000 Completed Product Development
3. Grant 01-Jan-2017 00000 00000 Completed Product Development
2. Grant 14-May-2016 $84K $750K Completed Product Development
1. Early Stage VC 30-Jul-2015 $750K $750K Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Mitotherapeutix Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
University of Connecticut Technology Incubation Program Accelerator/Incubator Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0

Mitotherapeutix Executive Team (4)

Name Title Board
Seat
Contact
Info
Robert Hennessey Chief Executive Officer, Manager & Board Member
Robert Hemley Chief Operating Officer & Board Member
John Talley Executive Officer & Board Member
Mercedes Rincon Co-Founder

Mitotherapeutix Board Members (3)

Name Representing Role Since Contact
Info
John Talley Mitotherapeutix Executive Officer & Board Member 000 0000
Robert Hemley Mitotherapeutix Chief Operating Officer & Board Member 000 0000
Robert Hennessey Mitotherapeutix Chief Executive Officer, Manager & Board Member 000 0000